Cough Syrup Abuse Prompts FDA to Consider Restrictions

Robitussin and Tylenol Cough could eventually go the way of nasal decongestants — behind the pharmacist’s counter. Increasing signs of abuse and injuries among adolescents have prompted U.S. regulators to consider dispensing restrictions for the over-the-counter cough syrups, Bloomberg reports.

Non-medical use of dextromethorphan, a cough suppressant that has been on the market since 1958, led to 7,988 visits to the emergency room in 2008, up from 4,634 in 2004, according to a government memo released last week.

The medicine can be found in products including Robitussin Cough & Chest Congestion, Tylenol Cough & Sore Throat, Vicks NyQuil Cough and Delsym.

Since 2006, pharmaceutical companies have tried to teach parents and educators about cough medicine abuse, known as “robo-tripping” or “skittling.”

Drug manufacturers expressed concern, however, about restrictions that would place a burden on consumers. “Our goal is to stop the intentional abuse of cough medicine while allowing for continued, responsible availability of these medicines,” said Elizabeth Funderburk, a spokeswoman for the Consumer Healthcare Products Association.

The Drug Enforcement Administration is recommending new restrictions on dextromethorphan, and a U.S. Food and Drug Administration advisory panel will meet to consider the issue on Sept. 14.

Print Print  

Like what we're doing? We'd appreciate your support.

2 comments to “Cough Syrup Abuse Prompts FDA to Consider Restrictions”

  1. Lebrun

    hi thanks for the info.

  2. Demir Leather

    hello, i just on your article on a coincidence, and ofcourse i start checking out whats here, the article gets really interesting after awhile. Thanks for putting it up, thanks and have a good evening

Leave a comment